Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments
Oropharyngeal mucositis is the acute inflammatory and ulcerative reaction of the oral mucosa following radiation therapy to the head and neck region. It is such a common problem that nearly all head and neck cancer patients develop some degree of mucositis. This complication is usually transient in...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-12-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | http://www.oncologyreviews.org/index.php/or/article/view/124 |
id |
doaj-04b2327d902d4cc68d90bc4c47fc750e |
---|---|
record_format |
Article |
spelling |
doaj-04b2327d902d4cc68d90bc4c47fc750e2020-11-25T03:40:39ZengPAGEPress PublicationsOncology Reviews1970-55571970-55652011-12-012310.4081/oncol.2008.164118Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatmentsWei Cheong Ngeow0Wen Lin Chai1Rosnah Binti Zain2Department of Oral & Maxillofacial Surgery Faculty of Dentistry, University of Malaya Kuala LumpurDepartment of General Dental Practice and Oral & Maxillofacial Imaging, Faculty of Dentistry, University of Malaya,Kuala LumpurDepartment of Oral Pathology, Oral Medicine and Periodontology Faculty of Dentistry, University of Malaya, Kuala LumpurOropharyngeal mucositis is the acute inflammatory and ulcerative reaction of the oral mucosa following radiation therapy to the head and neck region. It is such a common problem that nearly all head and neck cancer patients develop some degree of mucositis. This complication is usually transient in nature but it also represents an important clinical problem as it is a painful, debilitating, dose-dependent side effect for which there is no widely acceptable prophylaxis or effective treatment. As several authoritative groups have recently either undertaken systematic reviews or issued guidelines on the management of mucositis, it is the aim of this review instead, to provide an overview of all the remedies and pharmaceutical agents available, as well as highlighting to researchers the gaps that need to be filled.http://www.oncologyreviews.org/index.php/or/article/view/124Head and Neck Cancer - Radiation Therapy - Mucositis - Management - Pharmaceutical Agents |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wei Cheong Ngeow Wen Lin Chai Rosnah Binti Zain |
spellingShingle |
Wei Cheong Ngeow Wen Lin Chai Rosnah Binti Zain Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments Oncology Reviews Head and Neck Cancer - Radiation Therapy - Mucositis - Management - Pharmaceutical Agents |
author_facet |
Wei Cheong Ngeow Wen Lin Chai Rosnah Binti Zain |
author_sort |
Wei Cheong Ngeow |
title |
Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments |
title_short |
Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments |
title_full |
Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments |
title_fullStr |
Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments |
title_full_unstemmed |
Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments |
title_sort |
management of radiation therapy-induced mucositis in head and neck cancer patients. part ii: supportive treatments |
publisher |
PAGEPress Publications |
series |
Oncology Reviews |
issn |
1970-5557 1970-5565 |
publishDate |
2011-12-01 |
description |
Oropharyngeal mucositis is the acute inflammatory and ulcerative reaction of the oral mucosa following radiation therapy to the head and neck region. It is such a common problem that nearly all head and neck cancer patients develop some degree of mucositis. This complication is usually transient in nature but it also represents an important clinical problem as it is a painful, debilitating, dose-dependent side effect for which there is no widely acceptable prophylaxis or effective treatment. As several authoritative groups have recently either undertaken systematic reviews or issued guidelines on the management of mucositis, it is the aim of this review instead, to provide an overview of all the remedies and pharmaceutical agents available, as well as highlighting to researchers the gaps that need to be filled. |
topic |
Head and Neck Cancer - Radiation Therapy - Mucositis - Management - Pharmaceutical Agents |
url |
http://www.oncologyreviews.org/index.php/or/article/view/124 |
work_keys_str_mv |
AT weicheongngeow managementofradiationtherapyinducedmucositisinheadandneckcancerpatientspartiisupportivetreatments AT wenlinchai managementofradiationtherapyinducedmucositisinheadandneckcancerpatientspartiisupportivetreatments AT rosnahbintizain managementofradiationtherapyinducedmucositisinheadandneckcancerpatientspartiisupportivetreatments |
_version_ |
1724533656399118336 |